Lower riskDrug recall · FDA · Published February 22, 2024
Eugia recalls Tobramycin injection due to stability issues
Eugia US LLC recalls Tobramycin for Injection, USP, 1.2 grams per Pharmacy Bulk Package for potential stability issues. This product was manufactured in India and distributed to US pharmacies. Check your carton NDC 55150-470-06 and vial NDC 55150-470-01 for affected lots.
“Eugia recalls Tobramycin injection due to stability issues.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32801-eugia-recalls-tobramycin-injection-due-to-stability-issues. Based on FDA recall #D-0385-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0385-2024%22&limit=1).
Eugia US LLC recalled Tobramycin for Injection, USP, 1.2 grams per Pharmacy Bulk Package nationwide due to failed stability specifications, the FDA said on Feb. 22, 2024. The recall affects 1,160 vials distributed across the country.
How to tell if you have it
Brand: Eugia
Product: Tobramycin for Injection, USP, 1.2 grams per Pharmacy Bulk Package, Rx Only, For Intravenous Use, PHARMACY BULK PACKAGE NOT FOR DIRECT INFUSION
Carton NDC: 55150-470-06
Vial NDC: 55150-470-01
Lot codes: 3TB23001, 3TB23002
Expiration date: 04/30/2025
Quantity: 1,160 vials
The hazard
The product failed stability specifications because water determination results did not comply with the required specification. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Eugia US LLC has issued 14 other recalls since Dec. 28, 2022. Recent Eugia recalls include a Lidocaine injection recall on May 18, 2026, due to label scanning issues, and a Gentamicin Injection recall on May 29, 2025, for stability failure. Other recent recalls of similar products include Safecor Health Fluphenazine Elixir Recall (Aug. 13, 2026), Somerset Therapeutics Cisatracurium Besylate Injection Recall (Nov. 26, 2025), and Baxter Vancomycin Injection Recall (Aug. 6, 2026).
How to tell if you have this one
Check for carton NDC 55150-470-06 and vial NDC 55150-470-01. The affected lots are 3TB23001 and 3TB23002, expiring April 30, 2025.
Brand
Eugia
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for carton NDC 55150-470-06 and vial NDC 55150-470-01 on the packaging.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 22 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0385-2024 (February 22, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0385-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.